Table 1: The general information and laboratory data of the new diagnosed type 2 diabetic patients and non-diabetes mellitus.

ControlT2DM

Participants (M/F)35 (18/17)38 (18/20)
Age (years)43 ± 1345 ± 10
Body mass index (kg/m2)23.9 ± 3.325.5 ± 4.9
Waist circumference (cm)83.1 ± 6.092.2 ± 5.1
Systolic pressure (mmHg)125.1 ± 12.4138.0 ± 18.3
Diastolic pressure (mmHg)78.3 ± 8.286.1 ± 9.3
Fasting plasma glucose (mM)6.1 ± 0.97.4 ± 1.7*
HbA1c (%)6.0 ± 0.67.1 ± 0.6*
Fasting insulin (mIU/L)5.7 ± 2.89.2 ± 6.2*
HOMA-IR3.3 (2.5~4.6)5.5 (3.6~6.7)*
Fasting serum resistin (ng/mL)6.1 ± 0.612.3 ± 2.7*
Fasting saliva resistin (ng/mL)1.5 ± 0.3#3.4 ± 0.4*#
Fasting saliva flow rate (mL/min)2.2 ± 0.82.4 ± 1.1

Results are displayed as mean values ± standard deviation. Data of nonnormal distribution were described using the median (M) and quartile (Q1~Q4).
𝑃 < 0 . 0 5 : comparison of resistin level between T2DM group and non-diabetes mellitus group.
# 𝑃 < 0 . 0 1 : comparison between serum resistin level and saliva resistin level.